14
Feb

….I just can’t get rid of GNBTGenerex Biotechnolology Corp. (GNBT.OB) has been on my radar for several years and I have recommended it (or warned traders away) several times.  I got another email from a reader asking me to take another look at the stock.   I resisted at first, but decided to investigate.  What I found surprised me.

GNBT might actually be in a good place to take a look at again.

GNBT – The Company

The company is engaged in the research, development, and commercialization of drug delivery systems and technologies.  The drug that supposedly holds the greatest promise is Oral-lyn™ which is in Phase III clinical trials at several sites around the world.  Several other larger pharma companies have tried and failed to develop insulin sprays….GNBT appears to be succeeding.    The company is best known for developing a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs).  The Company’s proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company’s proprietary RapidMist™ device.

GNBT also has a suite of drugs centered around immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, and autoimmune diseases.   More information can be found on the Generex website at www.generex.com.

GNBT – The Stock

You can see just how beat down GNBT is from the chart below.  GNBT has really harmed its shareholders by more than doubling its share count over the past few years by entering some toxic financings.  The market is better for GNBT and its past few financings haven’t been too onerous.  Still the share count has exploded from around 110MM in 2008 to a bloated 270MM today.  The rumbles about a reverse split seem to have quieted with the strengthening of the economy.

The chart looks good for GNBT.  The stock appears to have put in a base at current levels and the MACD and Stochastics are looking promising.  the MACD appears to be about to cross and the oversold stochastics could add some strength to any rally.  The stock is pretty liquid and any good news will help this stock to jump.

sc-131

Do I trust GNBT?

GNBT has disappointed many traders over the past few years.  For a stock that has significantly underperformed over the past few years, I am somewhat surprised by the staunch support it receives on the boards and on other stock websites.  Clearly, they have some exciting drug potential.  The Amgen agreement could work out very nice for the company.  I still don’t trust it though.  IF you trade GNBT, be sure and put in a tight stop.  Any bad news could further weaken this stock.  However, I am looking for some recovery in the stock going forward.

Here is what I am looking at for entry/exit points

Last Close:              $0.238
Buy Opinion:          $0.22 – $0.25
Short Term Sell:   $0.35
Long Term Sell:     $0.75+

Good Luck and Great Trading,

Jeffrey Dean

About InvestorSoup

InvestorSoup.com is committed to provide intelligent commentary and solid analysis of small cap stocks, micro-cap stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily on the underserved OTC stocks market, or “penny stock” market, which has traditionally been shunned by Wall Street. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average daytrader is aware of them.

—————————————————————————————————————————————

Disclaimer

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Category : General Commentary | Blog Bookmark and Share
30
Apr

UNDT, POSC, SIXFQ, SCIA, PLBI, WLSI, LCRE, BGBR, IVOI, ARTS

Positron Corp. (OTC: POSC) is up 0.48% to $0.210. POSC chairman Patrick Rooney has confirmed in an interview with BioMedReports that while his company will be profitable this year, he sees much more profitability in the coming years. (OTC:POSC), ($POSC)

I like POSC.  I just don’t know if I trust this run up.  POSC has some really nice technology, but a lot of obstacles to profitability.  Capital equipment of the type that they manufacture is exactly “flying off the shelves”.  And, POSC seems to be Tim Sykes favorite short these days.

Sykes is calling the company and its viability into serious question.  In my opinion, this will be a 5 cent stock again before it is a $1.00 stock.

posc1

Six Flags Inc. (OTC: SIXFQ) is down 37.75% on above-average volume. (OTC:SIXFQ), ($SIXFQ)

I told you so!  Common shareholders are getting the shaft and the only direction for the shares is down!

SCI Engineered Materials Inc. (OTC: SCIA) $3.00 0.00% The company has announced significantly improved financial results for the first quarter., with revenues rising 18%, and earnings per diluted share coming in at $0.03 per share. (OTC:SCIA), ($SCIA)

Nice company, nice profits report…nobody cares!  Even with this great news, the stock only traded 5,000 shares

Proton Laboratories Inc. (OTC: PLBI) is up 6.67% on very strong volume. The company has recently said that it has posted additional information on OTCMarkets.com. (OTC:PLBI), ($PLBI)

Not much gong on with PLBI.  Technical indicators and trend are negative.  I looked for the info on OTC markets but didn’t find any.  This is a “Caveat Emptor” company, so be careful

Wellstar International Inc. (OTC: WLSI) is down 12.50% on above average volume. (OTC:WLSI), ($WLSI)

Lecere Corp. (PINK: LCRE) is down 22.22% to $0.0014. The company has said that it will begin a pilot project on May 3 to evaluate its initial SaaS Point of Sales offering at Nepo 42 in Portland, Oregon. (PINK:LCRE), ($LCRE)

Big Bear Mining Corp. (OTC: BGBR) is down 6.45% to $1.16. The company has announced that it has engaged Billiken Management Services to provide a comprehensive work program on all its properties in the Red Lake District. (OTC:BGBR), ($BGBR)

Ivoice Inc. (OTC: IVOI) is down 25.00% to $0.0003. (OTC: IVOI), ($IVOI)

Artfest International Inc. (OTC: ARTS) is down 4.26% to $0.0045. The company has said that it has signed an exclusive agreement for the release of Limited Edition licensed commemorative sports coins through its subsidiary, Artfest Direct. (OTC:ARTS), ($ARTS)

Call it a hunch, but I think that ARTS is a stock that you should put on your radar list.  I never call a bottom, but ARTS is sitting on support and I think could have a bounce in it.

ARTS tries really hard to make traders love them with lots of “important” PR’s . The latest PR claims that ARTS projects annual revenues of approximately $60 Million to $80 Million over the next 12 months.

They have been a high-flier in the past and could be again.  They have not been above doing stock promotions in the past and could again.  Here is their chart…mostly bad news and negative trend, but the stock is worth watching.

arts

Category : General Commentary | Blog Bookmark and Share
2
Mar

Sirius XM Radio (SIRI) has made an almost miraculous comeback from irrelevancy (and penny stock land) over the past few months.  SIRI has seen its stock rise from the low $.50′s at the end of 2009 to a recent high of around $1.15 just a few days ago.  This was very good news for the company.  Since it was facing a NASDAQ delisting and with the stock trading above the magic $1.00 mark for a period of time, SIRI was thinking it was “scot-free”.  Think again.

Last week’s drop (and this week’s continuing drop) was not surprising given the overheated condition of the stock from all indicators.  It is not clear what effect short sellers had in the decline since the short squeeze had been on for many months with the advance of the stock price.  SIRI fought through all of those challenges….that is until now.

SIRI has one more chance to regain compliance with NASDAQ regs if it can trade above $1.00 for 10 consecutive days before the March 15th date imposed by the exchange.  I don’t see that happening.  The reverse split that has been discussed seems the only option now despite management’s contention that they will be able to get a variance on appeal.  NOT BLOODY LIKELY.

SIRI should have executed the reverse split when they were so strong late last year.  The market was really pumped on SIRI and its progress.  Institutions were buying and retail investors were very happy with the run-up.  Now with a delisting notice sure to come, short sellers will be circling SIRI like sharks looking for blood.  I think the short term outlook for SIRI is definitely bearish.

Here is a chart that shows what I mean.

siri2

Is SIRI a dead dog?  Will shorters drive this one right back down to 50 cents (or lower) again.  I don’t think so.  SIRI is in a “stew of its own making”, but I think will be a good stock to buy on dips.  Right now, I would hold off (unless you are shorting the stock).  The boards and investor sentiment are telling me that this one has farther to fall.  Retail investors might not like it when they do the reverse stock split, but IMO it is inevitable.

Do your own due diligence.  It continues to be a hot topic on the boards that I monitor and it is fun to read what people write.  Make up your own mind.

Good luck and good trading,

Jeffrey Dean

Editor-in-Chief

—————————————————————————————————————————————————

<!– /* Font Definitions */ @font-face {font-family:”Cambria Math”; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-1610611985 1107304683 0 0 159 0;} @font-face {font-family:Cambria; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-1610611985 1073741899 0 0 159 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:”"; margin:0in; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:”Times New Roman”,”serif”; mso-fareast-font-family:”Times New Roman”;} .MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-size:10.0pt; mso-ansi-font-size:10.0pt; mso-bidi-font-size:10.0pt;} @page Section1 {size:8.5in 11.0in; margin:1.0in 1.25in 1.0in 1.25in; mso-header-margin:.5in; mso-footer-margin:.5in; mso-paper-source:0;} div.Section1 {page:Section1;} –>

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Category : General Commentary | Blog Bookmark and Share
24
Feb

I must apologize first for not blogging on Monday and Tuesday, but I was on a ski trip with the family and not thinking about the markets.  My alert for Monday (BLGW) is doing very well I’m happy to report.

I jumped back in to my research this morning and came across a great company that has solid prospects:  Cytomedix, Inc., a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis:physiological process involving the growth of new blood vessels from pre-existing vessels).

GTF’s AutoloGel System utilizes a unique technology that enables rapid isolation and activation of platelet rich plasma (PRP) from a patient’s own blood. The PRP is subsequently processed to produce a gel for application to the wound bed, re-establishing a balance needed for natural healing to occur. AutoloGel contains growth factors, cytokines and chemokines that are essential for normal wound healing. The AutoloGel System is used at the point-of care and is the only PRP System indicated for use in exuding wounds such as leg ulcers, pressure ulcers, diabetic ulcers and for the management of mechanically or surgically-debrided wounds.  The AutoloGel System is the only PRP system that is FDA cleared for the care of wounds.

The company is generating revenues and those revenues are increasing significantly.  They have cash-in-the-bank and NO long term debt….always a positive sign for me.  With the 2009 capital raise, that bought the company some time to execute on their plan.  Based upon what I have seen, they have high expectations for their AutoloGel System.

The chart indicates that the stock is trading near the bottom of its most recent trading range.

  • After a steep selloff, the stock might be ready to run again
  • An Amex stock, GTF is trading at attractive levels
  • The strongest support is at 40 cents (see the chart)…. I don’t think it will drop that far, but it could

gtf

I am recommending that traders put GTF on their radar screens.  I think the downside risk is low, but the upside is strong.

As always, do your own due diligence.

Good luck and good trading,

Jeffrey Dean

Editor

Category : General Commentary | Blog Bookmark and Share
4
Feb

I released this pick on my Twitter site a few days ago and have followed it since.  I didn’t have time to do a blog on it until now.  I think that the trend is ZAGG’s friend once again.

ZAGG was one of last year’s stock stars vaulting from $1.00 to almost $8.00.  And, like most stars in the stock market, it was a “shooting star” and its fall was almost as dramatic as its rise. The stock hit a low of $2.10 just a few days ago (that is when I posted it to Twitter) and has made a strong recovery.  A recovery that I think might have some legs.

This is strictly a chart play.

zagg

Oh, yeah…what does ZAGG do?  ZAGG Incorporated designs, manufactures, and distributes protective coverings, audio accessories, and power solutions for consumer electronic and hand-held devices.  ZAGG is solidly profitable, has cash in the bank and no debt.

Will ZAGG get hot again.  Watch it and see.

Jeffrey Dean

Category : General Commentary | Blog Bookmark and Share
2
Feb

I must admit that I am an alternative energy junkie.  I love all things alternative:  I love the almost infinite variety of wind, solar, biofuel, CO2 to gas technologies that are out there.  Each one of them is exciting on its own merits and each has a claim to be “The One” that makes it to the next level.  Could RZ be one of the winners?

Raser Technologies, Inc. (RZ – NYSE) is (from RZ’s website) an environmental energy technology company focused on geothermal power development and technology licensing.

RZ has two divisions:

  1. Raser’s Power Systems segment is seeking to develop clean, renewable geothermal electric power plants and bottom-cycling operations, incorporating licensed heat transfer technology.
  2. Raser’s Transportation and Industrial segment focuses on extended-range plug-in-hybrid vehicle solutions and using Raser’s award-winning Symetron™ technology to improve the torque density and efficiency of the electric motors and drive systems used in electric and hybrid-electric vehicle powertrains and industrial applications.

RZ is making only nominal revenues with large losses every quarter.  Looking through their website, press releases and 3rd party articles on them is impressive.  They really appear to have some great technology and prospects.  The Evergreen Clean Energy LLC joint venture seems to hold great promise.  Read the release hereEvergreen, a newly-formed alternative energy fund, has agreed to fund several RZ geothermal projects in the U.S. The recent news of the appointment of a new CEO, Nick Goodman, didn’t do much for the stock,  Mr. Goodman seems to have a solid resume and could be just the guy that the company needs….time will tell.

But, since we live in the real world, let’s talk RZ as it stands right now.  RZ has, according to its own balance sheet, maybe two quarters of life left based upon the present cash burn.  The liquidity ratios stink and the company has a great deal of debt (more than it can comfortably service along with huge R & D expenses each Q).

The chart, on its face, doesn’t offer much hope either. The prolonged bearish slide doesn’t appear to be slackening.  Or does it? Candlestick chart analysis gives us some insight into the chart.  Most of the sticks during this decline were long bodies or Maurbozo’s (in a declining chart, that means that sellers ruled).  Buyers put little resistance and the stock was bid down every day significantly.  Except, that is, for the last two days.  We are actually seeing tails develop on the candles which means that buyers and sellers are struggling over the stock.  In fact, yesterday’s candle shows that the sellers drove it down, but the sellers brought it back up to close near the top of its trading range.  The key for RZ is to watch for confirmation that the sellers are getting “exhausted” and that the buyers are coming back in. The oversold stochastics is an important indicator, but until the MACD intensity diminishes, the stock could continue to fall.

Here is my annotated chart:

rz

Any good news could really send this one soaring.  I recommend that traders watch this one and keep it on the radar.  Technology-wise, RZ appears to be a “good horse to back”.  If they can get some financing for general operations and if the Evergreen deal comes through, this could be a HUGE winner.

Lots of variables, though…..

Good luck and good trading,

Jeffrey Dean

Category : General Commentary | Blog Bookmark and Share
4
Jan

Wind power stocks have demonstrated extreme volatility over the past year and today’s blog subject, Nacel Energy, Corporation (NCEN), is no different.  From an opening 2009 price of around $2.00, the stock dropped below $1.00 on two occasions only to rally back to around $1.50.   August 2009  was the last high (around $1.50).  The stock has declined steadily since that date to now trade around 60 cents.   NCEN has not stopped churning out press releases to keep the public interested and informed, but it hasn’t seemed to work. Even November’s news of a successful capital raise didn’t do anything to raise the stock.

Let’s take the nickel tour of NCEN.  According to the company, they are one of the first U.S. public companies exclusively developing utility class wind power generation facilities. NCEN’s domestic market niche is the development of 10-30 MW projects in Class 4 or higher wind corridors with favorable existing transmission infrastructure.

They have 5 projects that that are currently in some stages of completion (i.e. off the drawing board) – 4 in TX and 1 in AZ.  The Company believes that they could have several of these sites “up and running” by the 3rd Q of 2010 IF things go according to plan.

The capital raise of $750,000 (press release here) was at good terms for both the investor and current shareholders.  It sets a near term value for the shares of 90 cents (with discounts, the floor price could be 75 cents).  The terms also includes warrants that if exercised over the life of the agreement could raise another $3 to $4 Million for the company.  The market didn’t seem to care.

The chart shows a slow decline that is remarkable for how unremarkable that it has been. The price trend for the last 6 months has been down as indicated in the enclosed chart.

necn

I NEVER attempt to call a bottom on a stock.  I cannot say for sure how much farther NECN could fall, but I am going to watch it.   Even though the stochastics are deeply oversold and would appear to indicate that a bounce is possible, the trend is definitely down.  The old saying that “trend trumps oscillators” certainly applies here.

Having said that, I actually LIKE the company.  I think that they are well positioned to succeed.  The combination of wind power dynamics , a successful capital raise, an experienced management team and projects in various stages of completion makes me bullish on NCEN.  By “windpower dynamics” I mean that there is a perfect storm of incentives and reasons for windpower to succeed.  With government subsidies in place, alternative energy quotas being imposed on utility companies, specialized companies devoted to financing wind turbines, the chances for windpower companies like NCEN to succeed increase exponentially.

I encourage my readers to tour their website which has lots of good information in it.

This is definitely a radar stock for me.

***********************************************************************************************************

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Category : General Commentary | Blog Bookmark and Share
21
Dec

Reading a chart is sometimes like telling fortunes by reading tea leaves.  You may have a rare insight into a person or a situation by reading the leaves….or, you could just be full of crap!

I don’t think I am full of “it” when I recommend my members take a look at Microvision, Inc. (MVIS).  As recently as two months ago, the company’s stock hit a 52-week high of $5.75.  The stock couldn’t maintain its momentum and began to give most of the gain back and then recently announced a discounted equity offering that “finished ‘em off”.  It is a good thing to raise capital, but MVIS set the price for the stock with an offering priced at $3.00 (all to one institutional investor, by the way) and that predictably drove the price to that level.  It has recovered slightly, but still hovers around $3.19 as of Friday.

MVIS, especially with the latest capital raise, will have a strong balance sheet.  Even before this raise, the balance sheet was in good shape:  Good ratios, little or no debt, cash-in-the-bank, etc…  However, they are going to need every dollar with the burn rate that they are experiencing.  Great technology, but markets are only just beginning to be tapped and they are still in a big R & D push.

MVIS, the company, offers a technology platform that enables next generation display and imaging products.  Their main markets are displays in vehicles, projectors, wearable displays and bar code scanners.  I recommend that traders check out the MVIS Website. They have some cool technology that they think will be the standard in the years to come.

I also like the chart. The stock has taken its beating with the bad news (to traders) about the capital raise and the technical indicators are looking more favorable.

mvis

MVIS is a good radar stock, IMO.  The stock should be avoided for any break below the $3.05 range, but I don’t believe that it will break down.  The fact that an institutional investor is willing to pony up $9.3 MM for stock in a company that doesn’t make a profit, but has nice technology (and 115 patents at last count), is pretty impressive.

Long term this might be a good stock to own, but since I live in the short-term world….look for a ‘pop” in the near term.

Do your due diligence, but I like what I see with MVIS

Good luck and good trading

*****************************************************************************************************

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Category : General Commentary | Blog Bookmark and Share
3
Nov

I love getting emails from my members and readers….I feel that the feedback makes my site better.  I especially love stories from people that have traded one of my alerts or blog picks and banked! I also get lots of emails from people asking me to take a look at a stock for them.  Some of them are absolute train wrecks, but others have merit.

Like today’s blog subject:  Fieldpoint Petroleum Corporation (FPP).  One of my readers, Jon, asked me to take a look at it.  I liked what I saw.  It has a real business, decent fundamentals and a great chart.

FPP is a producing oil and gas company.  According to the company, they own over 300 wells in Oklahoma, Louisiana, New Mexico, Texas and Wyoming.  They do a good job of press releasing so traders can get a flavor of their progress….and, they seem to be making some.

I mentioned that they were a producing oil and gas company and, when I took a look at their financials, they are not too bad.  Many oil and gas producers seem to be built solely on hype. Not FPP…they actually have revenues (but no profits).  Their balance sheet, while not strong, will get them through the near term.

Insiders own 38.9% of the company while there is even some institutional ownership.  The company does something on their website that I have never seen before in a company like this:  they have an “ethics” section on their site.  A nice touch and I hope they live up to it.

What really caught my eye is the chart:

  • Stochastics indicate that the stock is in oversold status
  • The MACD is above the zero line, but is indicating bearishness
  • Volume has remained steady (around 50K shares per day)
  • Volatility is present in this stock and it could spike again on good news (as it has in the past)

fpp

No one can say when a stock will move, but based on the chart this one looks like it might have a move in its future.  The nice thing about the chart is that those moves have been multi-day moves rather than a one-day wonder.

Check out FPP.  Their company website really doesn’t have a lot of information on it, but they are not shy about press releasing.  I plan on watching them closely.  Oil and Gas prices remain high and that should be a positive for a stock like FPP.

Good luck and good trading

*********************************************************************

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Category : General Commentary | Blog Bookmark and Share
28
Oct

I have a Rite Aid near my home that I have stopped in to on several occasions.  I can tell you I am in no hurry to go back. The store looks old and tired and is not laid out very well.  The store personnel didn’t seem to care that I was even there.

I don’t know if my local store is a valid indicator of the state of Rite Aid Corporation around the country, but my experience seems to be indicative of RAD’s larger problems.  Customers are staying away in droves.  Whether it is strictly the economy or other issues,

Financially, their balance sheet is still a mess. Their income statement, while showing signs of improvement (sales holding steady, operating profits the last two Q’s) still doesn’t contain lots of good news.  RAD Corporate issued a corporate update (considerably more upbeat than my quick analysis) – you can read it by clicking HERE

I did not come to kill Rite Aid as a stock or a company, but my belief is that the company is not “out of the woods” yet.

However, as a chart play, there might be a reason to look at RAD.

My chart analysis shows me that:

  • The stock is sitting near a good support level
  • Accum/Dist indicates that the stock may be in accumulation again
  • Stochastics indicate that RAD is oversold
  • Bearish MACD signal is lessening

See for yourself!

rad

To my mind, RAD is a short-term play only.  Big profits were made in its 2009 run from 20 cents to over $2.00.  I don’t know if RAD has that kind of move again or not (I kinda doubt it), but watch for any surges.  I would never recommend buying RAD on the HOPE that it will go up, but if the chart is any indicator then there MIGHT be a bounce in it.

Good luck and good trading

Category : General Commentary | Blog Bookmark and Share
22
Sep

GVBP

Still looks like it has farther to fall.  The HYPE MACHINE may kick back in and send this one back up, but it seems that the market is getting immune to GVBP news.  The stock is in distribution, the Stochastics are indicating that the stock is still being dumped.  Tim Sykes is polishing the knives for the ritual disembowlmenet of this company.

Here is a link to their chart:  GVBP Chart

INAR

Polular topic in our chat room.  Lots of good news that will mean $’s to the bottom line.  Certainly the Internet won’t go away.  Interesting chart play.

Here is a link to their chart: INAR Chart

ADMP

One of my blog alerts at 20 cents….zoomed to 45 cents intraday and has since retraced much of that gain.  I still expect to see a few more days of retracement, but this is a radar stock.  They supposedly have a huge hit with their injectable “EPI Pen” (Epinephrinepre-filled syringe).

Here is a link to their chart:  ADMP Chart

Three likely stocks.  One (GVBP) likely to go down and Two (INAR and ADMP) likely to go up…IMHO

_______________________________________________________________________________________

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Category : General Commentary | Blog Bookmark and Share
18
Sep

Today’s stock is purely a penny stock chart play.  It is a stock very much on the minds of traders.  It ranked as the #1 search on Board Central yesterday.

XDSL or MPhase Technologies is a development-stage enterprise and has anointed themselves as having “The Battery Technology of Tomorrow”.  They have a great website with a “feast” of information (click here to check it out) and appear to have some good technology.  I see some intrinsic value in the type of nano-battery technology that they are claiming to be in the forefront of.

What they don’t have are earning and profits, a good balance sheet and near-term prospects for either. I will probably get an angry email from someone at the company, but as a recovering CPA I can’t help but cringe at their financials.  However, companies like this can limp along for quite a long time.  And who knows, they may just “break it big” and be the next battery standard and make themselves and their investors lots and lots of money.

But this blog is all about their chart:

xdsl-9-18-09

Oversold according to Stochastics, MACD is starting to turn positive (although below the zero line), GREAT volatility, strong volume, RSI is positive and stock is under accumulation again…..what’s  not to like?

Forget about stuff like financials, going concerns, etc…  This could be a great penny stock play for the next week or two. Watch it and see what it does.

All joking aside, I like the company, its patented technology and its prospects.  They still have quite a hill to climb before they are ‘out of the woods”, but I give them a better than 50/50 chance.

Category : General Commentary | Blog Bookmark and Share
8
Sep

After several days off, I am itching to get back in the markets.  As I was doing my screens this morning, I came across Nephros Inc. (NEPH.OB). The company is a small cap company in the medical device business and has a chart that I found interesting.

neph-9-8-09

The company was a penny stock until it  had a huge run up starting in late May when it ran from 12.5 cents to $2.50 in mid-August! Since then, the stock has cooled off and dropped down to $1.38.  Looking at the chart, it looks to me that the profit takers have driven the price down and now might be a good opportunity to profit on the bounce that I believe is coming.

Why do I think their might be a bounce? NEPH appears to be a pretty solid company.  They have a solid balance sheet….cash in bank and no long-term debt.  They have revenues, but no profits yet.  With two main product lines, NEPH appears to have good potential.  Their main business is End Stage Renal Disease products in the area of filtration.  They also have patented (and received FDA approval on) a line of water filters that just recently received $2MM from the Office of Naval Research to expand development of their water microfilter for military use.

The stochastics indicate that the stock is oversold, but the MACD is still solidly bearish.  This stock may trend down for a few more days, but it appears to me to be ready for a bounce.  The news on the company has been very positive and I can see why investors bid this up from $12.5 cents to $2.50.  I don’t see this stock going back to penny stock status.  If NEPH can commercialize its water microfilter product, the “sky would be the limit”.

Radar list this one…check back daily and see if it is turning

Category : General Commentary | Blog Bookmark and Share
3
Jul

The markets are closed and I will be catching up on paperwork and practicing with my new software toy:  Camtasia Studio.  Starting next week, I will be unveiling a new feature.  I will be doing video charting of “stocks of interest”.  It should be fun and educational for my readers.

But, today is about Independence Day (the celebration not the movie). I am guilty of enjoying the parades and BBQ’s, but not remembering the significance of this day.  I live in the “Live Free or Die” state, New Hampshire and consider myself a patriot, but I have lost touch with the “reason for the season”.  I remember taking the Duck Tour of Boston and the tour guide pointed out the spot where the populace gathered to hear the Declaration of Independence read in 1776.  Men, women and children wept unashamedly as they listened to those words that set a course for a new nation.

“…..We hold these truths to be self-evident, that all men are created equal, that they are endowed by their Creator with certain unalienable rights, that among these are life, liberty and the pursuit of happiness…..”

I encourage you to enjoy your BBQ’s and parades this weekend, but take a minute and thank those first patriots that risked everything so that  you and I can enjoy the freedom we have today.  God Bless America!

american-flag

I will leave with a link to YouTube where you can listen to Ray Charles AWESOME version of America The Beautiful:  http://www.youtube.com/watch?v=N7Wt4XlXUrc

Category : General Commentary | Blog Bookmark and Share
26
Jun

I spend lots of time in our chat room and enjoy the interplay with the people in the room.  Passion is the name of the game in there.  Those in the room might be passionate about the “Flavor of the Day” or one of the “Old Standby’s” like GNTA, GNBT, SFIO, HEB, etc….

I noticed today that the room is really high on IGNT.  They might have something there, too!

Here is the chart…notice the flag pattern that is shaping up.  The company has had good news lately and more news will only help the stock.  With flag patterns, the popular thought is the stock is taking a breather before taking its next step up.

ignt-chart

It is trading near the top of the Bollinger Bands (although the bands are farther apart than I would like).  It is in neither an oversold or overbought position according to the Stochastics.  The MACD is tickling the zero line and might mean some accumulation is going on.

I almost made it through this entire writeup and didn’t tell you what the company does!  Typical!  I find that I trade many stocks and really don’t know what they do.  All I am looking at is the chart.

Ingen Technologies, Inc. (IGNT) is a medical equipment manufacturer that is focused on the respiratory and medical diagonistic markets.  It is a typical “Penny FDA” as one of the guys in our room called it.  Little or no cash, going-concern issues, limited sales….but GREAT POTENTIAL.  And, in this market that is what matters the most.

Definitely worth putting on your radar.

Category : General Commentary | Blog Bookmark and Share
26
Jun

Today’s Stock Alerts include: Kimberly-Clark Corp. (NYSE: KMB), PetroQuest Energy Inc. (NYSE: PQ), Pfizer Corp. (NYSE: PFE), Dress Barn Inc. (Nasdaq: DBRN) and McCormick & Co. Inc. (NYSE: MKC).

Kimberly-Clark Corp. (NYSE: KMB) Stock Alert – KMB Streamlines Organization to Boost Profitability and Cash Flow; Eyes $150 million in Annualized Savings

In a move expected to improve its competitive position, health and hygiene company Kimberly-Clark Corp. (NYSE: KMB) recently announced it will reduce its global salaried workforce by 1,600 positions.

The roughly 3% cut in workforce is expected to yield annualized savings of about $150 million, the company said. Approximately $60 million, or 10 cents per share, in savings is expected to benefit the company’s results during the second half of 2009. continue

Category : Daily Soup | Blog Bookmark and Share
22
Jun

Featuring FINL’s plan to get rid of its Man Alive brand; MRK’s recent request from the FTC; MRVL’s updated Q2 guidance; VRSN’s analyst upgrade; AAPL’s iPhone 3GS; and CBS’ new CFO.

 

Today’s Stock Alerts include: Finish Line Inc. (Nasdaq: FINL), Merck Co. Inc. (NYSE: MRK), Marvell Technology Group Ltd. (Nasdaq: MRVL), VeriSign Inc. (Nasdaq: VRSN), Apple Inc. (Nasdaq: AAPL) and CBS Corp. (NYSE: CBS).

 

Finish Line Inc. (Nasdaq: FINL) Stock Alert – FINL Plans to Exit Unprofitable Man Alive Business; Guides Q1 Lower

 

Mall-based specialty retailer Finish Line Inc. (Nasdaq: FINL) today announced a plan to exit its unprofitable Man Alive business as it focuses on its core Finish Line business.

 

According to the press release, Finish Line’s board approved a definitive agreement with Man Alive Acquisition LLC (MA), an entity controlled by Jimmy Khezrie, the owner and operator of Jimmy Jazz stores, under which MA will assume certain assets and liabilities of Man Alive. Man Alive is a street fashion retailer offering men’s and women’s name brand fashions from the designers. As of April 17, 2009, Finish Line operated 82 Man Alive stores in 19 states. continue

Category : Daily Soup | Blog Bookmark and Share
11
Jun

A drop in new jobless claims and the growth in retail sales gave Wall Street a kick in today’s morning and mid-day sessions; today’s stock alert features several market movers, most of which secured gains by noon.

Today’s Stock Alerts Include: U.S. Steel (NYSE: X), AK Steel Holding Company (NYSE: AKS), CR Bard Inc. (NYSE: BCR), Sprint Nextel Corp. (NYSE: S), NVIDIA Corp. (NASDAQ: NVDA) and Ford Motor Co. (NYSE: F).

U.S. Steel (NYSE: X) Stock Alert – U.S. Steel Upgraded by Morgan Stanley

Shares of U.S. Steel (NYSE: X) and its steelmaker competitors have enjoyed investor enthusiasm for the sector during the sharp rebound in basic materials commodities. Additional fuel for investors came Wednesday following Morgan Stanley’s announcement of its upgrade of U.S. Steel, as reported by the Associated Press (AP). Shares of U.S. Steel gained 3.36% this morning, trading at $41.47. continue

Category : Daily Soup | Blog Bookmark and Share

About Us

Traders make huge profits from penny stocks! Our Hot stock alerts are sent the second we identify likely stocks that we feel will fly! We are passionate about small caps, penny stocks and sub-penny stocks. We are the resource that you need to profit from penny stocks. Bookmark us and check back frequently. Read more »

Subscribe

Subsribe via RSS Feed Reader

Contact Us

InvestorSoup.com
4828 S. Broadway #182 | Tyler, TX 75703

Privacy Policy    |    Related Links

Verifying Email ...

close this